CollPlant Biotechnologies (CLGN) Share-based Compensation (2018 - 2026)
CollPlant Biotechnologies (CLGN) reported Share-based Compensation of $180000.0 for Q1 2026, down 52.88% on a YoY basis from $382000.0 in Q1 2025, and up 1100.0% quarter-over-quarter from -$18000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Share-based Compensation (2018 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Share-based Compensation for 9 years, with the latest figure at $180000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 52.88% year-over-year to $180000.0; the trailing twelve-month figure through Mar 2026 stood at $797000.0 (down 55.99% YoY), and the FY2025 full-year result was $999000.0, down 41.88% from the prior year.
- Share-based Compensation for Q1 2026 stood at $180000.0, up from -$18000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $680000.0 in Q3 2022, with the low at -$18000.0 in Q4 2025.
- Historically, Share-based Compensation has averaged $412294.1 across 5 years, with a median of $439000.0 in 2022.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 84.78% — and 2025, when it tumbled 104.25%.
- CollPlant Biotechnologies' Share-based Compensation stood at $439000.0 in 2022, then climbed by 28.47% to $564000.0 in 2023, then fell by 24.82% to $424000.0 in 2024, then slumped by 104.25% to -$18000.0 in 2025, then soared by 1100.0% to $180000.0 in 2026.
- The last three Share-based Compensation figures came in at $180000.0 (Q1 2026), -$18000.0 (Q4 2025), and $282000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26.47 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | 180,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180,000.00 |
| Mar 31, 2026 | 180,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Sep 30, 2024 | 515,000.00 |
| Sep 30, 2024 | 515,000.00 |
| Jun 30, 2024 | 490,000.00 |
| Jun 30, 2024 | 490,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Dec 31, 2023 | 564,000.00 |
| Dec 31, 2023 | 564,000.00 |